Living with me is a challenge – I am complicated, expensive, very demanding and often highly misunderstood. A myriad of defiant characteristics, I require great effort, constant attention and unwavering patience. I am diabetes.

You’ve likely heard a lot about modular content over the last few years. It’s often described as being the future of content in pharma. But why? What exactly does it give you that traditional content doesn’t?

Many life sciences companies are experiencing the same problem: global brand strategies are often excellent but aren’t having the expected impact. So, what’s happening?